These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17887804)

  • 1. Valuing children's health: a comparison of cost-utility analyses for adult and paediatric health interventions in the US.
    Ladapo JA; Neumann PJ; Keren R; Prosser LA
    Pharmacoeconomics; 2007; 25(10):817-28. PubMed ID: 17887804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges in health state valuation in paediatric economic evaluation: are QALYs contraindicated?
    Ungar WJ
    Pharmacoeconomics; 2011 Aug; 29(8):641-52. PubMed ID: 21604821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in the measurement of health utilities in published cost-utility analyses.
    Brauer CA; Rosen AB; Greenberg D; Neumann PJ
    Value Health; 2006; 9(4):213-8. PubMed ID: 16903990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Family Spillover Effects in Pediatric Cost-Utility Analyses.
    Lavelle TA; D'Cruz BN; Mohit B; Ungar WJ; Prosser LA; Tsiplova K; Vera-Llonch M; Lin PJ
    Appl Health Econ Health Policy; 2019 Apr; 17(2):163-174. PubMed ID: 30350218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of classic utilities to published pediatric cost-utility studies.
    Finnell SM; Carroll AE; Downs SM
    Acad Pediatr; 2012; 12(3):219-28. PubMed ID: 22075466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 30 years of pharmaceutical cost-utility analyses: growth, diversity and methodological improvement.
    Neumann PJ; Fang CH; Cohen JT
    Pharmacoeconomics; 2009; 27(10):861-72. PubMed ID: 19803540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The changing face of the cost-utility literature, 1990-2012.
    Neumann PJ; Thorat T; Shi J; Saret CJ; Cohen JT
    Value Health; 2015 Mar; 18(2):271-7. PubMed ID: 25773562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-utility analyses in diabetes: a systematic review and implications from real-world evidence.
    Zhong Y; Lin PJ; Cohen JT; Winn AN; Neumann PJ
    Value Health; 2015 Mar; 18(2):308-14. PubMed ID: 25773567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discounting in cost-utility analysis of healthcare interventions: reassessing current practice.
    Cohen BJ
    Pharmacoeconomics; 2003; 21(2):75-87. PubMed ID: 12515570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring health preferences for use in cost-utility and cost-benefit analyses of interventions in children: theoretical and methodological considerations.
    Prosser LA; Hammitt JK; Keren R
    Pharmacoeconomics; 2007; 25(9):713-26. PubMed ID: 17803331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-utility analysis in spine care: a systematic review.
    Kepler CK; Wilkinson SM; Radcliff KE; Vaccaro AR; Anderson DG; Hilibrand AS; Albert TJ; Rihn JA
    Spine J; 2012 Aug; 12(8):676-90. PubMed ID: 22784806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Systematic Review of Methods Used by Pediatric Cost-Utility Analyses to Include Family Spillover Effects.
    Lamsal R; Yeh EA; Pullenayegum E; Ungar WJ
    Pharmacoeconomics; 2024 Feb; 42(2):199-217. PubMed ID: 37945777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth and quality of the cost-utility literature, 1976-2001.
    Neumann PJ; Greenberg D; Olchanski NV; Stone PW; Rosen AB
    Value Health; 2005; 8(1):3-9. PubMed ID: 15841889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A scoping review of pediatric economic evaluation 1980-2014: do trends over time reflect changing priorities in evaluation methods and childhood disease?
    Sullivan SM; Tsiplova K; Ungar WJ
    Expert Rev Pharmacoecon Outcomes Res; 2016 Oct; 16(5):599-607. PubMed ID: 27659998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost-effectiveness of oral health interventions: A systematic review of cost-utility analyses.
    Hettiarachchi RM; Kularatna S; Downes MJ; Byrnes J; Kroon J; Lalloo R; Johnson NW; Scuffham PA
    Community Dent Oral Epidemiol; 2018 Apr; 46(2):118-124. PubMed ID: 28925508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Societal Preferences for Interventions with the Same Efficiency: Assessment and Application to Decision Making.
    Shiroiwa T; Saito S; Shimozuma K; Kodama S; Noto S; Fukuda T
    Appl Health Econ Health Policy; 2016 Jun; 14(3):375-85. PubMed ID: 26940671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive league table of cost-utility ratios and a sub-table of "panel-worthy" studies.
    Chapman RH; Stone PW; Sandberg EA; Bell C; Neumann PJ
    Med Decis Making; 2000; 20(4):451-67. PubMed ID: 11059478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Many Miles to Go: A Systematic Review of the State of Cost-Utility Analyses in Brazil.
    Campolina AG; Rozman LM; Decimoni TC; Leandro R; Novaes HM; De Soárez PC
    Appl Health Econ Health Policy; 2017 Apr; 15(2):163-172. PubMed ID: 27798797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-utility analyses in spine care: a qualitative and systematic review.
    Nwachukwu BU; Schairer WW; Shifflett GD; Kellner DB; Sama AA
    Spine (Phila Pa 1976); 2015 Jan; 40(1):31-40. PubMed ID: 25341977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.